Current Issue
April 2020 | Volume 19 | Issue 4
Editorials
Exacerbation of Pediatric Periorificial Dermatitis: A Novel Adverse Reaction
Deposition and Retention of Hair Care Product Residue Over Time on Specific Skin Areas
Is It Time to Redefine Lidocaine Administration Guidelines in Mohs Surgery?
The Cash Pharmacy Model May Effectively Lower Prescription Drug Prices
A Survey Study of Human Papillomavirus Vaccination Practices by Dermatologists
Erratum
Original Articles
Thread Lifts: A Critical Analysis of Treatment Modalities
Background: Thread lifting procedure was developed to reverse the aging process and restore youthful appearance by retightening and lifting the skin. Different models of absorbable an...
Read MoreRecapture Rate of Brodalumab in Patients With a Lapse in Treatment
The National Psoriasis Foundation has emphasized the importance of achieving skin clearance targets throughout the course of treatment. However, patients with psoriasis often stop and restart treatmen...
Read MoreSafety of Combining Facial Lifting with Suspension Threads and Microfocused Ultrasound With Visualization
Suspension threads are used to lift lax facial skin; however, there is concern about the safety of combining suspension threads with microfocused ultrasound (MFU) as it may change the structure and in...
Read MoreEvaluation of Patient-Reported Outcomes with Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
Background: Patients with moderate-to-severe psoriasis can have symptoms resulting in significant impact on patient-reported outcomes (PROs). The effect of etanercept (ETN) in moderat...
Read MoreCombination of Calcium Hydroxylapatite Diluted With Normal Saline and Microfocused Ultrasound With Visualization for Skin Tightening
Background/Objectives: Treatment options for the correction of age-related changes in skin include the use of energy-based devices and dermal fillers. In this study, we evaluate the c...
Read MoreThe Effect of a Ceramide-Containing Product on Stratum Corneum Lipid Levels in Dry Legs
Roughly equimolar concentrations of ceramides, cholesterol, and free fatty acids arranged in lamellar sheets form the intercellular lipid barrier in the stratum corneum (SC). Intercellular lipid defic...
Read MoreLight Emitting Diode Phototherapy for Skin Aging
Skin aging is associated with changes that include atrophy, pigmentation, decreased ability for wound healing, and rhytides. Recently, there has been growing research interest and consumer demand for ...
Read MoreHalobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Lower Extremities
Background: Plaque psoriasis can occur in all body regions, with the trunk and extremities among the most commonly affected areas. A fixed combination halobetasol propionate 0.01%/taz...
Read MoreDeveloping a Topical Adjunct to Injectable Procedures
Injectable procedures have come to play an enormous part in everyday aesthetic medical practice. Whether its use is directed at volumizing with fillers, decreasing volume using enzymes, skin-tightenin...
Read MoreTreatment of Plaque Psoriasis With an Excimer Laser Utilizing an Optimal Therapeutic UVB Dose Protocol
Background: Traditionally, treatment with the excimer laser requires determining the minimal erythema dose on healthy skin or using plaque-based induration; however, these protocols o...
Read More
Features
Case Reports
Treating Field Cancerization by Ablative Fractional Laser and Indoor Daylight: Assessment of Efficacy and Tolerability
Objective: To assess if ablative fractional laser combined with indoor daylight photodynamic therapy are effective and safe for the treatment of skin field cancerization associated wi...
Read More
Supplements
CME: Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update
Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy ha...
Read MoreCME: Re-examining the Optimal Use of Neuromodulators and the Changing Landscape: A Consensus Panel Update
Since initial US Food and Drug Administration approval of botulinum toxin type A (BoNT-A) for aesthetic use in 2002, clinical evidence and experience with BoNT-A and understanding of facial anatomy ha...
Read MoreCME/CE: ABOUT FACE: Navigating Neuromodulators and Injection Techniques for Optimal Results
Interest in the cosmetic use of neuromodulators for facial rejuvenation is increasing among physicians, other practitioners, and patients alike, and an expanding array of formulations and reported app...
Read More
